Table 4 |
||||
|
GSEA tests for enrichment of HCC- and hepatitis-associated gene sets |
||||
|
Gene Set Name |
Size |
ES |
NES |
NOM p-value |
|
|
||||
|
Up-regulated in acute liver treatment |
||||
|
|
||||
|
KUROKAWA_5FU_IFN_SENSITIVE_VS_RESISTANT_DN |
25 |
0.585 |
1.642 |
0.025 |
|
|
||||
|
WONG_IFNA_HCC_RESISTANT_VS_SENSITIVE_UP |
10 |
0.507 |
1.407 |
0.046 |
|
|
||||
|
Down-regulated in acute liver treatment |
||||
|
|
||||
|
HBX_HEP_UP |
12 |
-0.540 |
-1.460 |
0.038 |
|
|
||||
|
Up-regulated in chronic liver treatment |
||||
|
|
||||
|
HCC_SURVIVAL_GOOD_VS_POOR_DN |
112 |
0.452 |
1.549 |
0.000 |
|
|
||||
|
Down-regulated in chronic liver treatment |
||||
|
|
||||
|
None |
||||
|
|
||||
|
Results for gene sets representing Hepatocellular carcinoma (HCC) and hepatitis, tested for enrichment by GSEA following methylmercury treatment. Here, we test whether liver-associated sets are enriched following methylmercury exposure. Size refers to the number of genes in the set; ES and NES are the enrichment scores and normalized enrichment scores (respectively) for the set; NOM p-value is the nominal p-value for the NES. Descriptions of each set (and lists of constituent genes) can be found by searching for set names at the MSigDB [8]. |
||||
|
Thomas et al. BMC Genomics 2011 12:66 doi:10.1186/1471-2164-12-66 |
||||